advertisement
Chen Y 25
Showing records 1 to 25 | Display all abstracts from Chen Y81315 Rapid network meta-analysis using data from Food and Drug Administration approval packages is feasible but with limitations
Wang L
Journal of Clinical Epidemiology 2019; 114: 84-94
81413 Discovery and Validation of Circulating Hsa-miR-210-3p as a Potential Biomarker for Primary Open-Angle Glaucoma
Liu Y
Investigative Ophthalmology and Visual Science 2019; 60: 2925-2934
80886 Mutant RAMP2 causes primary open-angle glaucoma via the CRLR-cAMP axis
Gong B
Genetics in Medicine 2019; 21: 2345-2354
81315 Rapid network meta-analysis using data from Food and Drug Administration approval packages is feasible but with limitations
Rouse B
Journal of Clinical Epidemiology 2019; 114: 84-94
80886 Mutant RAMP2 causes primary open-angle glaucoma via the CRLR-cAMP axis
Zhang H
Genetics in Medicine 2019; 21: 2345-2354
81413 Discovery and Validation of Circulating Hsa-miR-210-3p as a Potential Biomarker for Primary Open-Angle Glaucoma
Wang Y
Investigative Ophthalmology and Visual Science 2019; 60: 2925-2934
81315 Rapid network meta-analysis using data from Food and Drug Administration approval packages is feasible but with limitations
Marks-Anglin A
Journal of Clinical Epidemiology 2019; 114: 84-94
81413 Discovery and Validation of Circulating Hsa-miR-210-3p as a Potential Biomarker for Primary Open-Angle Glaucoma
Chen Y
Investigative Ophthalmology and Visual Science 2019; 60: 2925-2934
80886 Mutant RAMP2 causes primary open-angle glaucoma via the CRLR-cAMP axis
Huang L
Genetics in Medicine 2019; 21: 2345-2354
81315 Rapid network meta-analysis using data from Food and Drug Administration approval packages is feasible but with limitations
Duan R
Journal of Clinical Epidemiology 2019; 114: 84-94
80886 Mutant RAMP2 causes primary open-angle glaucoma via the CRLR-cAMP axis
Chen Y
Genetics in Medicine 2019; 21: 2345-2354
81413 Discovery and Validation of Circulating Hsa-miR-210-3p as a Potential Biomarker for Primary Open-Angle Glaucoma
Fang X
Investigative Ophthalmology and Visual Science 2019; 60: 2925-2934
81315 Rapid network meta-analysis using data from Food and Drug Administration approval packages is feasible but with limitations
Shi Q
Journal of Clinical Epidemiology 2019; 114: 84-94
81413 Discovery and Validation of Circulating Hsa-miR-210-3p as a Potential Biomarker for Primary Open-Angle Glaucoma
Wen T
Investigative Ophthalmology and Visual Science 2019; 60: 2925-2934
80886 Mutant RAMP2 causes primary open-angle glaucoma via the CRLR-cAMP axis
Shi Y; Tam PO
Genetics in Medicine 2019; 21: 2345-2354
81413 Discovery and Validation of Circulating Hsa-miR-210-3p as a Potential Biomarker for Primary Open-Angle Glaucoma
Xiao M
Investigative Ophthalmology and Visual Science 2019; 60: 2925-2934
81315 Rapid network meta-analysis using data from Food and Drug Administration approval packages is feasible but with limitations
Quach K
Journal of Clinical Epidemiology 2019; 114: 84-94
80886 Mutant RAMP2 causes primary open-angle glaucoma via the CRLR-cAMP axis
Zhu X
Genetics in Medicine 2019; 21: 2345-2354
81315 Rapid network meta-analysis using data from Food and Drug Administration approval packages is feasible but with limitations
Chen Y
Journal of Clinical Epidemiology 2019; 114: 84-94
81413 Discovery and Validation of Circulating Hsa-miR-210-3p as a Potential Biomarker for Primary Open-Angle Glaucoma
Chen S; Zhang X
Investigative Ophthalmology and Visual Science 2019; 60: 2925-2934
80886 Mutant RAMP2 causes primary open-angle glaucoma via the CRLR-cAMP axis
Huang Y
Genetics in Medicine 2019; 21: 2345-2354
81315 Rapid network meta-analysis using data from Food and Drug Administration approval packages is feasible but with limitations
Cameron C; Schmid CH
Journal of Clinical Epidemiology 2019; 114: 84-94
80886 Mutant RAMP2 causes primary open-angle glaucoma via the CRLR-cAMP axis
Lei B; Sundaresan P
Genetics in Medicine 2019; 21: 2345-2354
81315 Rapid network meta-analysis using data from Food and Drug Administration approval packages is feasible but with limitations
Li T
Journal of Clinical Epidemiology 2019; 114: 84-94
80886 Mutant RAMP2 causes primary open-angle glaucoma via the CRLR-cAMP axis
Li X; Jiang L; Lin Y; Lu F; Chen L; Li Y; Leung CK; Guo X; Zhang S; Huang G; Wu Y; Zhou T; Shuai P; Tham CC; Weisschuh N; Krishnadas SR; Mardin C; Reis A; Yang J
Genetics in Medicine 2019; 21: 2345-2354
